Rochester Home Infusion’s comprehensive care model is designed to enhance outcomes for patients needing intravenous therapies before and/or after receiving a transplant. There are many reasons a transplant patient might need IV therapy, whether they need magnesium for hypomagnesemia, antibiotics due infection or immunosuppressants to prevent rejection. We support IV therapies for patients receiving all types of transplants including bone marrow and solid-organ transplants.
Our RHI clinicians were trained in top ranking hospitals and are experts in monitoring transplant patients needing IV therapies. We understand the unique balance of preventing transplant rejection, managing medication side effects, and the risks of immunosuppression in fighting opportunistic infections. Our clinicians collaborate with your physician team to help implement the best treatment plan for you, manage and prevent side effects, and monitor your response to therapy. We have clinicians on-call 24/7 and we can connect with your physician to assist with medical concerns.
Home infusion minimizes exposure to health-care associated infection (HAI), a major risk for many transplant patients. The Center for Disease Control deems HAI as a major threat to patient safety. CDC’s HAI Prevalence survey in 2011 estimated 722,000 HAIs in U.S. acute care hospitals. Additionally, about 75,000 patients with HAIs died during their hospitalizations.*